Viking Therapeutics Inc (NASDAQ: VKTX) is -15.68% lower on its value in year-to-date trading and has touched a low of $20.28 and a high of $99.41 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The VKTX stock was last observed hovering at around $38.88 in the last trading session, with the day’s loss setting it -4.95%.
Currently trading at $33.93, the stock is -18.48% and -32.38% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 7.75 million and changing -12.73% at the moment leaves the stock -43.15% off its SMA200. VKTX registered 61.34% gain for a year compared to 6-month loss of -42.86%. The firm has a 50-day simple moving average (SMA 50) of $50.9322 and a 200-day simple moving average (SMA200) of $59.93075.
The stock witnessed a -31.05% gain in the last 1 month and extending the period to 3 months gives it a -48.47%, and is -20.22% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 7.22% over the week and 5.67% over the month.
Viking Therapeutics Inc (VKTX) has around 27 employees, a market worth around $3.78B and $0.00M in sales. Distance from 52-week low is 67.31% and -65.87% from its 52-week high. The company has generated returns on investments over the last 12 months (-10.87%).
The EPS is expected to shrink by -4.65% this year, but quarterly earnings will post 0.00% year-over-year. Quarterly sales are estimated to shrink 0.00% in year-over-year returns.
Viking Therapeutics Inc (VKTX) Top Institutional Holders
567.0 institutions hold shares in Viking Therapeutics Inc (VKTX), with institutional investors hold 78.01% of the company’s shares. The shares outstanding are 111.43M, and float is at 107.97M with Short Float at 18.03%. Institutions hold 75.89% of the Float.
The top institutional shareholder in the company is FMR LLC with over 16.54 million shares valued at $876.8 million. The investor’s holdings represent 15.9876% of the VKTX Shares outstanding. As of 2024-06-30, the second largest holder is VANGUARD GROUP INC with 10.1 million shares valued at $535.26 million to account for 9.7599 of the shares outstanding. The other top investors are BLACKROCK INC. which holds 6.03 million shares representing 5.8248% and valued at over $319.45 million, while STATE STREET CORP holds 4.9513 of the shares totaling 5.12 million with a market value of $271.54 million.
Viking Therapeutics Inc (VKTX) Insider Activity
The most recent transaction is an insider sale by Lian Brian, the company’s President & CEO. SEC filings show that Lian Brian sold 194,490 shares of the company’s common stock on Jan 06 ’25 at a price of $42.75 per share for a total of $8.31 million. Following the sale, the insider now owns 2.37 million shares.
Viking Therapeutics Inc disclosed in a document filed with the SEC on Jan 06 ’25 that Mancini Marianna (Chief Operating Officer) sold a total of 54,215 shares of the company’s common stock. The trade occurred on Jan 06 ’25 and was made at $42.75 per share for $2.32 million. Following the transaction, the insider now directly holds 0.37 million shares of the VKTX stock.
Still, SEC filings show that on Jan 06 ’25, ZANTE GREG (Chief Financial Officer) disposed off 50,309 shares at an average price of $42.75 for $2.15 million. The insider now directly holds 165,259 shares of Viking Therapeutics Inc (VKTX).
